BioSpace News Archive

Press Releases

Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine

January 23, 2026

·

17 min read

Press Releases

Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

January 23, 2026

·

2 min read

Press Releases

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules

January 23, 2026

·

4 min read

2006 James Gathany Captured by James Gathany, Centers for Disease Control's biomedical photographer, this 2006 image depicted the exterior of the new "Tom Harkin Global Communications Center", otherwise known as Building 19, located on the organization's Roybal Campus in Atlanta, Georgia. The facility houses the CDC's Information Center/Library, auditoria and meeting halls, which are used to accommodate in-house staff meetings, and national/international conferences hosted by the CDC, and the National Center for Health Marketing's, Division of Creative Services, which includes a full service television broadcast facility. The exhibit area currently features the "Global Symphony", the first of several permanently installed exhibitions, and changing exhibitions that focus on a variety of public health topics. The exhibits in the Center are self-guided, and require no advance reservations. Additional curriculum-based exhibits and programming will be added in the future. Tom Harkin Global Communications Center Exhibit Area Centers for Disease Control and Prevention - 1600 Clifton Road, N.E., Atlanta, Georgia 30333 - Hours: Monday Friday, 9 am 5 pm, except for federal holidays Admission is free - Government-issue photo ID is required for entry. Please note that CDC is a working federal facility and as such does not provide public tours of its campus and laboratories. - For more information please call 404-639-0830.

Vaccines

ACIP Chair Questions Polio Vaccines, Values Individual Choice Over Public Benefit

“I don’t like established science,” ACIP chairperson Kirk Milhoan said in an interview on the Why Should I Trust You? podcast. “Science is what I observe.”

January 23, 2026

·

2 min read

·

Tristan Manalac

Vaccines

Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg

Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine development, Moderna CEO Stéphane Bancel said this week.

January 23, 2026

·

2 min read

·

Tristan Manalac

Concept art showing a money icon and human hands

Funding

China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill

Corxel will use the fundraising proceeds to advance the oral GLP-1 therapy CX11 through mid-stage development in the U.S., as well as prepare for its Phase III studies.

January 23, 2026

·

1 min read

·

Tristan Manalac

Pros and cons collage. Mixed media thumbs up and thumbs down hand gestures with speech bubbles. Review concept, positive and negative feedback vector illustration.

Immunology and inflammation

Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway

The mixed data from the Phase III COAST 2 trial follows an underwhelming data drop from COAST 1 in September that Leerink Partners said “fell well below expectations.”

January 23, 2026

·

2 min read

·

Tristan Manalac

Press Releases

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

January 23, 2026

·

6 min read

Press Releases

MustGrow Closes $2.0 Million Non-Brokered LIFE Offering